<p>The quality of Indian medicines is being questioned again, this time in neighbouring Sri Lanka where health officials are seeking a probe after fatalities and complications were reported across the nation.</p>

<p>Health Secretary Janaka Sri Chandragupta told News 1st that they are probing the quality of these Indian medicines which were imported via the Indian Line of Credit recently.</p>

<p>According to local media reports, a patient at the Intensive Care Unit of the Peradeniya Hospital died after being administered one of the medicines sourced from India.</p>

<p>Director of the Peradeniya Teaching Hospital, Dr Arjuna Thilakaratne, told News 1st that the woman was administered Indian-made anaesthetic Bupivacaine for hernia surgery, some two months ago.</p>

<p>He said that another woman who was admitted to the same hospital to deliver a child died after being given the same Indian anaesthetic drug.</p>

<p>This comes after the 10 visually impaired patients who were administered Indian medicines after eye surgery complained of complications in May 2023.</p>

<p>The doctors noted the “presence of germs” in the eye medication as a reason for the&nbsp;patients’ condition. Following this, the Sri Lankan Health Ministry blacklisted the use of Prednisolone eye drops.</p>

<h2><strong>Two Indian firms in the dock</strong></h2>

<p>The report prompted the Indian drug regulator, Central Drugs Standard Control Organisation, to launch an investigation&nbsp;against a pharmaceutical company based in Gujarat. The probe is currently underway.</p>

<p>Indiana Ophthalmics from Wadhwan-Gujarat has been told to investigate the cause, according to reports.</p>

<h2><strong>WHO labels 4 cough syrups as 'substandard products',&nbsp;Indian pharma&nbsp;company in the dock?</strong></h2>

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/who-labels-four-cough-syrups-as-substandard-products-indian-pharmaceutical-company-in-the-dock-523024/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

<p>Notably, prior to these incidents, Transparency International Sri Lanka, an NGO that fights against corruption, had filed a petition in the Sri Lankan Supreme Court, challenging the decision of the Cabinet and health authorities to procure drugs from unregistered suppliers.</p>

<p>The petition questioned the national drug regulator’s role in providing a waiver of registration to allow for the swift import of essential drugs.</p>

<p>Gujarat-based Savorite Pharmaceuticals (Pvt) Limited and Chennai-based Kausikh Therapeutics were named as respondents. Early in April, the Supreme Court granted leave to proceed in the case and suspended imports from these companies, the Hindu newspaper reported.</p>

<h2><strong>Not the first time</strong></h2>

<p>This is not the first time that Indian-made medicines were taken down over their quality. In February this year, the World Health Organization (WHO) said that around 90 kids died last year of kidney failure, 20 in Uzbekistan and 70 in Gambia, after allegedly consuming India-made&nbsp;cough syrups.</p>

<p>Gambian and Swiss tests found the syrups contained toxic industrial-grade glycol rather than the safe but costlier pharmaceutical-grade glycerine, the agency said.</p>

<p>The US also began investigating the EzriCare Artificial Tears, an over-the-counter eye drop produced by Global Pharma Healthcare in Chennai, India, after linking it to complications and death.</p>

<h2><strong>Relying on India-made drugs</strong></h2>

<p>India is one of the leading manufacturers of low-cost generic drugs. The pharmaceutical sector is one of the fastest-growing sectors with a market value of $42 billion.</p>

<p>It supplies 40 per cent of US generics, a quarter of UK medicines and 45 per cent of Africa’s generics. Many of its factories are world-class and millions of people around the world consume Indian-made drugs without incident.</p>

<p><em>(With inputs from agencies)</em></p>

<p><strong>WATCH WION LIVE HERE</strong></p>

<p><iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe></p>


The quality of Indian medicines is being questioned again, this time in neighbouring Sri Lanka where health officials are seeking a probe after fatalities and complications were reported across the nation.

The quality of Indian medicines is being questioned again, this time in neighbouring Sri Lanka where health officials are seeking a probe after fatalities and complications were reported across the nation. Health Secretary Janaka Sri Chandragupta told News 1st that they are probing the quality of these Indian medicines which were imported via the Indian Line of Credit recently. According to local media reports, a patient at the Intensive Care Unit of the Peradeniya Hospital died after being administered one of the medicines sourced from India. Director of the Peradeniya Teaching Hospital, Dr Arjuna Thilakaratne, told News 1st that the woman was administered Indian-made anaesthetic Bupivacaine for hernia surgery, some two months ago. He said that another woman who was admitted to the same hospital to deliver a child died after being given the same Indian anaesthetic drug. This comes after the 10 visually impaired patients who were administered Indian medicines after eye surgery complained of complications in May 2023. The doctors noted the “presence of germs” in the eye medication as a reason for the patients’ condition. Following this, the Sri Lankan Health Ministry blacklisted the use of Prednisolone eye drops. Two Indian firms in the dock The report prompted the Indian drug regulator, Central Drugs Standard Control Organisation, to launch an investigation against a pharmaceutical company based in Gujarat. The probe is currently underway. Indiana Ophthalmics from Wadhwan-Gujarat has been told to investigate the cause, according to reports. WHO labels 4 cough syrups as 'substandard products', Indian pharma company in the dock? Notably, prior to these incidents, Transparency International Sri Lanka, an NGO that fights against corruption, had filed a petition in the Sri Lankan Supreme Court, challenging the decision of the Cabinet and health authorities to procure drugs from unregistered suppliers. The petition questioned the national drug regulator’s role in providing a waiver of registration to allow for the swift import of essential drugs. Gujarat-based Savorite Pharmaceuticals (Pvt) Limited and Chennai-based Kausikh Therapeutics were named as respondents. Early in April, the Supreme Court granted leave to proceed in the case and suspended imports from these companies, the Hindu newspaper reported. Not the first time This is not the first time that Indian-made medicines were taken down over their quality. In February this year, the World Health Organization (WHO) said that around 90 kids died last year of kidney failure, 20 in Uzbekistan and 70 in Gambia, after allegedly consuming India-made cough syrups. Gambian and Swiss tests found the syrups contained toxic industrial-grade glycol rather than the safe but costlier pharmaceutical-grade glycerine, the agency said. The US also began investigating the EzriCare Artificial Tears, an over-the-counter eye drop produced by Global Pharma Healthcare in Chennai, India, after linking it to complications and death. Relying on India-made drugs India is one of the leading manufacturers of low-cost generic drugs. The pharmaceutical sector is one of the fastest-growing sectors with a market value of $42 billion. It supplies 40 per cent of US generics, a quarter of UK medicines and 45 per cent of Africa’s generics. Many of its factories are world-class and millions of people around the world consume Indian-made drugs without incident. (With inputs from agencies) WATCH WION LIVE HERE

Alarm in Sri Lanka over India-made medicines causing deaths and complication

India may face a shortage of antibiotics, vitamins, and even diabetes medicines if no alternative source of raw material for these drugs is found soon.

India may run out of common drugs or medicines by the February end

Govt working on altenate plan as India may run out of prominent drugs

india-medicines

India Medicines, News on India Medicines, stories on India Medicines, articles on India Medicines, India Medicines stories at Wion, India Medicines news, India Medicines latest news

india medicines

Alarm in Sri Lanka over India-made medicines causing deaths and complication

India may run out of common drugs or medicines by the February end

Govt working on altenate plan as India may run out of prominent drugs